Ependymoblastoma is a rare embryonal neoplasm of the nervous system, and the entity is even rare with distant metastasis. This case can help refine the existing literature and provide lessons for the management of other patients with ependymoblastoma. The present case concerns an adolescent with supratentorial ependymoblastoma, who received gross-total resection (GTR), postoperative radiotherapy, and six cycles of chemotherapy, with disease-free survival (DFS) of about 5.3 years. Subsequently, pulmonary metastasis occurred, but no intracranial lesion was found. Finally, combined treatment with radiotherapy and chemotherapy significantly reduced the lung lesions, with progression-free survival (PFS) of 10 months and long-term survival of 6.3 years. This case indicates that the lung metastases of ependymoblastoma are relatively sensitive to radiation, but lung metastases have not completely disappeared. Perhaps, increasing the radiation dose to lung metastases can improve the efficacy, which is worth exploring.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395982PMC
http://dx.doi.org/10.3389/fneur.2022.964856DOI Listing

Publication Analysis

Top Keywords

lung metastases
12
pulmonary metastasis
8
ependymoblastoma
5
ependymoblastoma pulmonary
4
metastasis adolescent
4
case
4
adolescent case
4
case report
4
report ependymoblastoma
4
ependymoblastoma rare
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!